TYK2 Inhibitors for the Management of Plaque Psoriasis:
Which of Your Patients May Benefit?
Podcast 1: Post-test

Questions marked with a * are required
100%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
Deucravacitinib has shown a _____ fold selectively for _______ over other JAKs?
A 40 year old male has psoriasis on 25% of his body. He has lost efficacy to multiple biologics. What would be a possible treatment option for him?
What is your job role?
What is your type of practice?
How many years have you been in practice?
Please estimate the number of patients with Plaque Psoriasis that you treat each month:
Were the following learning objectives met?
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Interpret results from studies assessing treatment options with different mechanisms of action for patients with moderate-to-severe plaque psoriasis
Identify patients with moderate-to-severe plaque psoriasis who may benefit from a TYK2 inhibitor
Please rate your confidence in your ability to evaluate data regarding targeted treatments for patients with Plaque Psoriasis on a scale of 1 to 5, where 1 means "not confident at all," and 5 means "very confident."
1
2
3
4
5
Confidence
As a result of this course, I will likely make changes to my practice.
If YES, in which of the following categories? (Please check all that apply)
In particular, as a result of this course, I will be more likely to implement the following changes:
(Please check all that apply)
What barriers may prevent/inhibit changes in practice recommended in this activity?
 (Please check all that apply.):
Please evaluate this activity as a whole.
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
The learning format was interactive and engaging
The content was pertinent to my professional needs
The activity will ultimately benefit patient care
I would recommend this activity to colleagues
Do you feel a commercial product, device, or service was inappropriately promoted in this educational activity? 
If YES, please comment:
What was the most effective aspect(s) of this learning activity? (Please check all that apply.):
Do you have suggestions for improving the session or for topics for future activities?
 (Please check all that apply.):
Please evaluate the faculty: Jerry Bagel, MD
Med Learning Group has my permission to fax or email information to me about further programs.
At times, MLG partners to conduct educational outcomes analyses on treatment and/or diagnosis behavior that are all deidentified and rolled-up across all learners
Any additional comments are welcome below. 
Powered by QuestionPro